| Title |
Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma
|
|---|---|
| Published in |
Annals of Surgical Oncology, October 2014
|
| DOI | 10.1245/s10434-014-4169-5 |
| Pubmed ID | |
| Authors |
John F. Thompson, Sanjiv S. Agarwala, B. Mark Smithers, Merrick I. Ross, Charles R. Scoggins, Brendon J. Coventry, Susan J. Neuhaus, David R. Minor, Jamie M. Singer, Eric A. Wachter |
| Abstract |
This international, multicenter, single-arm trial assessed efficacy and safety of intralesional rose bengal (PV-10) in 80 patients with refractory cutaneous or subcutaneous metastatic melanoma. |
X Demographics
The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 7 | 41% |
| Costa Rica | 1 | 6% |
| Belgium | 1 | 6% |
| Unknown | 8 | 47% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 14 | 82% |
| Practitioners (doctors, other healthcare professionals) | 2 | 12% |
| Scientists | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 2% |
| Netherlands | 1 | 2% |
| France | 1 | 2% |
| Unknown | 56 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 11 | 19% |
| Student > Ph. D. Student | 8 | 14% |
| Other | 7 | 12% |
| Student > Bachelor | 7 | 12% |
| Student > Postgraduate | 3 | 5% |
| Other | 12 | 20% |
| Unknown | 11 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 24 | 41% |
| Agricultural and Biological Sciences | 4 | 7% |
| Biochemistry, Genetics and Molecular Biology | 4 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 5% |
| Chemistry | 3 | 5% |
| Other | 9 | 15% |
| Unknown | 12 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 191. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 March 2023.
All research outputs
#188,789
of 23,963,877 outputs
Outputs from Annals of Surgical Oncology
#23
of 6,754 outputs
Outputs of similar age
#1,852
of 263,654 outputs
Outputs of similar age from Annals of Surgical Oncology
#2
of 96 outputs
Altmetric has tracked 23,963,877 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,754 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 263,654 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 96 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.